帝京大学 · 国際教育研究所 · 講師

研究キーワードnon-small cell lung cancer・thoracic chemoradiotherapy・durvalumab consolidation・EGFR-mutant NSCLC・lung squamous cell carcinoma・thoracic oncology・bevacizumab-based chemotherapy

ここは公開データのプレビューです。個別の適合理由、連絡角度、保存機能はログイン後に利用できます。

• Prospective analysis of factors precluding the initiation of durvalumab from an interim analysis of a phase II trial of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small cell lung cancer in Japan (SAMURAI study).
• A Phase II Trial on Osimertinib as a First-Line Treatment for EGFR Mutation-Positive Advanced NSCLC in Elderly Patients: The SPIRAL-0 Study.
• Ramucirumab Plus Docetaxel for Patients with Non-small cell Lung Cancer with Brain Metastases: A Multicenter, Open-Label Single-Arm Phase II Trial.
• Importance and difficulty of differentiating BMA-induced AFF prodromal symptoms from hormonal therapy-related femoral pain

• 公式プロフィール